Clinical Trial Update: Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of GLPG0974 in adults with Ulcerative Colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GLPG0974

Snippet

Sponsor: Galapagos NV | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED